Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03701932 · ClinicalTrials.gov registry record · NA
Mental Activity During (TMS) Therapy for Depression
A NA study, sponsored by Augusta University.
- Completed
- Registry status
- NA
- Development phase
- 11
- Enrollment target
NCT03701932: Completed NA study, sponsored by Augusta University.
NCT03701932 is a NA study that has completed, run by Augusta University. The registered enrollment target is 11 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03701932, a NA study, has completed, sponsored by Augusta University.
- COMPLETED
- Registry status
- NA
- Development phase
- 11 participants
- Enrollment target
Study Summary
The purpose of the study is to assess the effects of different types of mental activity performed while receiving transcranial magnetic stimulation (TMS) for the treatment of major depressive disorder. Our primary aim for this study is to assess the feasibility of combining TMS and computer based cognitive exercise in patients with major depressive disorder who may also have some degree of cognitive dysfunction, and to formally measure changes in mood and cognition over the course of the study.
Primary Outcome
Administers computerized neuropsychological tests for research studies
Interventions
- BEHAVIORAL TMS and Lumosity®cognitive retraining
- BEHAVIORAL TMS and non cognitive computer games
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 11 participants |
| Start Date | 2015-03-06 |
| Est. Completion | 2019-07-31 |
| Phase | NA |
What the finished NCT03701932 record still lists
NCT03701932 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 11 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 2 interventions - of which TMS and Lumosity®cognitive retraining is the first listed.
NCT03701932 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03701932 about?
NCT03701932 is a clinical study titled "Mental Activity During (TMS) Therapy for Depression". The purpose of the study is to assess the effects of different types of mental activity performed while receiving transcranial magnetic stimulation (TMS) for the treatment of major depressive disorder. Our primary aim for this study is to assess the feasibility of combining TMS and computer based co...
What is the current status of trial NCT03701932?
This trial is currently completed. It is a NA study. The enrollment target is 11 participants. The study started on 2015-03-06. Estimated completion is 2019-07-31.
What interventions are being tested in trial NCT03701932?
The interventions under investigation include: TMS and Lumosity®cognitive retraining (BEHAVIORAL), TMS and non cognitive computer games (BEHAVIORAL).
Who is sponsoring clinical trial NCT03701932?
This trial is sponsored by Augusta University, which has 106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03701932's enrollment target sits among peer trials
11 1927th of 2000 higher than 74 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03114462 · 11 participants · Phase 1
Trial of Stereotactic HYpofractionateD RadioAblative (HYDRA) Treatment of Laryngeal Cancer
- NCT06039709 · 11 participants · Phase 1
Sonodynamic Therapy in Patients With Recurrent GBM
- NCT06425380 · 11 participants · NA
Pilot Open-Label Trial of Resistant Potato Starch in Patients With Cirrhosis and Overt Hepatic Encephalopathy
- NCT06472661 · 11 participants · Early Phase 1
FUSA With Intratumoral PolyICLC in Regionally Advanced Resectable Melanoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI